《盈利預喜》津上機床中國(01651.HK)料首三財季純利按年增長115%
津上機床中國(01651.HK)發盈喜,預期截至2021年12月31日止首三季純利將達到5.33億元人民幣,按年增長約115%,主要受惠於期內全球經濟持續恢復,國內外製造行業持續呈現對加工設備的旺盛需要,尤其海外市場需求旺盛,增長勢頭明顯。
受宏觀環境影響,公司預期,截至2022年3月31日止財政年度的首三季度銷售延續去年強勁勢頭,各主要機型均有良好銷售業績,未來將繼續提高生產效率,降低成本及完善產品線,拓寬數控高精密機床的用途,並進一步擴大銷售網路。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.